社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
财经观象台
IP属地：未知
+关注
帖子 · 6
帖子 · 6
关注 · 0
关注 · 0
粉丝 · 0
粉丝 · 0
财经观象台
财经观象台
·
05-20
$MIRXES-B(02629)$
居家自检能代替医院吗？不能。不过，它可以做一个合格的前哨。Mirxes觅瑞在泰国推出的HELICORapid和FITRapid两款居家癌症风险筛查试剂盒，分别用于检测幽门螺旋杆菌感染和粪便隐血——这两项分别是胃癌、结直肠癌的重要风险信号。居家产品负责“揪出可疑对象”，被筛出的高风险人群再进入医疗体系，接受觅瑞的miRNA血液精准检测。早筛不是要把每个人都吓一跳，而是帮每个人找到适合自己的筛查节奏。
看
252
回复
评论
点赞
1
编组 21备份 2
分享
举报
财经观象台
财经观象台
·
05-20
$Caris Life Sciences, Inc.(CAI)$
看
221
回复
评论
点赞
1
编组 21备份 2
分享
举报
财经观象台
财经观象台
·
04-16
$MIRXES-B(02629)$
近期举办的西郊会议，再次将消化道肿瘤早筛的规范化、规模化建设推向行业焦点。觅瑞在会上同步发布两项重磅研究计划，背后离不开其成熟的早筛技术与产品支撑。觅小卫作为核心落地产品，凭借稳定的检测性能与无创筛查优势，已在临床与市场端得到广泛应用。此次启动的百万人群队列研究，也将进一步验证卫小觅在真实世界中的应用价值，推动产品从技术领先走向普惠大众，为国内胃癌早筛普及提供更坚实的支撑。
看
657
回复
评论
点赞
1
编组 21备份 2
分享
举报
财经观象台
财经观象台
·
03-19
$MIRXES-B(02629)$
2026年两会卫健委明确划定肺癌、结直肠癌、胃癌等重点癌症高危人群与规范筛查标准，代表委员纷纷建言扩大筛查覆盖面、推进医保支付，叠加《健康中国行动》等政策落地，层层加码筑牢行业根基。觅瑞的核心产品觅小卫®精准契合政策导向，手握国内胃癌早筛三类医疗器械注册证，完美匹配胃癌高危人群的筛查需求，踩准了行业发展的核心节奏。这份顶层设计不仅为早筛普及指明方向，更让合规深耕的企业迎来前所未有的发展窗口期，紧跟政策步伐，才能抢占先机、拉开与同行的差距。
看
995
回复
评论
点赞
1
编组 21备份 2
分享
举报
财经观象台
财经观象台
·
01-15
$MIRXES-B(02629)$
觅瑞拥有自主研发的miRNA检测专利，其基于miRNA技术研发推出的胃癌早筛产品觅小卫®已经获得第三类医疗器械注册证了，这也是国内首批合规上市的癌症早筛试剂盒，填补了我国无创胃癌早筛领域的空白，有重要的行业意义。
看
779
回复
评论
点赞
1
编组 21备份 2
分享
举报
财经观象台
财经观象台
·
2025-10-09
今年在港股上市的生物科技企业Mirxes觅瑞，他们的核心产品是通过检测血液miRNA标志物来完成胃癌筛查，用到的是液体活检技术。作为胃癌高危人群较多的亚洲，这款产品前途不可限量！所以最近也是被建银国际行研报告给出跑赢大盘的评级，而且目标价格是100港元，股价还有潜力的！资本市场也会非常看好，据了解继被纳入港股通后，南向资金流动也很活跃。
看
1,065
回复
评论
点赞
1
编组 21备份 2
分享
举报
加载更多
热议股票
{"i18n":{"language":"zh_CN"},"isCurrentUser":false,"userPageInfo":{"id":"4223082579780710","uuid":"4223082579780710","gmtCreate":1759979391003,"gmtModify":1768441175461,"name":"财经观象台","pinyin":"cjgxtcaijingguanxiangtai","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/379ecbe3a955be0e4ded631cc9a6779e","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":0,"tweetSize":6,"questionSize":0,"limitLevel":999,"accountStatus":1,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[],"userBadgeCount":0,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":566198031017264,"gmtCreate":1779266334114,"gmtModify":1779266336706,"author":{"id":"4223082579780710","authorId":"4223082579780710","name":"财经观象台","avatar":"https://static.tigerbbs.com/379ecbe3a955be0e4ded631cc9a6779e","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4223082579780710","authorIdStr":"4223082579780710"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02629\">$MIRXES-B(02629)$</a> 居家自检能代替医院吗？不能。不过，它可以做一个合格的前哨。Mirxes觅瑞在泰国推出的HELICORapid和FITRapid两款居家癌症风险筛查试剂盒，分别用于检测幽门螺旋杆菌感染和粪便隐血——这两项分别是胃癌、结直肠癌的重要风险信号。居家产品负责“揪出可疑对象”，被筛出的高风险人群再进入医疗体系，接受觅瑞的miRNA血液精准检测。早筛不是要把每个人都吓一跳，而是帮每个人找到适合自己的筛查节奏。","listText":"<a href=\"https://laohu8.com/S/02629\">$MIRXES-B(02629)$</a> 居家自检能代替医院吗？不能。不过，它可以做一个合格的前哨。Mirxes觅瑞在泰国推出的HELICORapid和FITRapid两款居家癌症风险筛查试剂盒，分别用于检测幽门螺旋杆菌感染和粪便隐血——这两项分别是胃癌、结直肠癌的重要风险信号。居家产品负责“揪出可疑对象”，被筛出的高风险人群再进入医疗体系，接受觅瑞的miRNA血液精准检测。早筛不是要把每个人都吓一跳，而是帮每个人找到适合自己的筛查节奏。","text":"$MIRXES-B(02629)$ 居家自检能代替医院吗？不能。不过，它可以做一个合格的前哨。Mirxes觅瑞在泰国推出的HELICORapid和FITRapid两款居家癌症风险筛查试剂盒，分别用于检测幽门螺旋杆菌感染和粪便隐血——这两项分别是胃癌、结直肠癌的重要风险信号。居家产品负责“揪出可疑对象”，被筛出的高风险人群再进入医疗体系，接受觅瑞的miRNA血液精准检测。早筛不是要把每个人都吓一跳，而是帮每个人找到适合自己的筛查节奏。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/566198031017264","isVote":1,"tweetType":1,"viewCount":252,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":566198121542328,"gmtCreate":1779266272981,"gmtModify":1779266274950,"author":{"id":"4223082579780710","authorId":"4223082579780710","name":"财经观象台","avatar":"https://static.tigerbbs.com/379ecbe3a955be0e4ded631cc9a6779e","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4223082579780710","authorIdStr":"4223082579780710"},"themes":[],"title":"","htmlText":"<a target=\"_blank\" href=\"https://laohu8.com/S/CAI\">$Caris Life Sciences, Inc.(CAI)$</a>","listText":"<a target=\"_blank\" href=\"https://laohu8.com/S/CAI\">$Caris Life Sciences, Inc.(CAI)$</a>","text":"$Caris Life Sciences, Inc.(CAI)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/566198121542328","isVote":1,"tweetType":1,"viewCount":221,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":554166655817760,"gmtCreate":1776329232846,"gmtModify":1776329789938,"author":{"id":"4223082579780710","authorId":"4223082579780710","name":"财经观象台","avatar":"https://static.tigerbbs.com/379ecbe3a955be0e4ded631cc9a6779e","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4223082579780710","authorIdStr":"4223082579780710"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02629\">$MIRXES-B(02629)$</a> 近期举办的西郊会议，再次将消化道肿瘤早筛的规范化、规模化建设推向行业焦点。觅瑞在会上同步发布两项重磅研究计划，背后离不开其成熟的早筛技术与产品支撑。觅小卫作为核心落地产品，凭借稳定的检测性能与无创筛查优势，已在临床与市场端得到广泛应用。此次启动的百万人群队列研究，也将进一步验证卫小觅在真实世界中的应用价值，推动产品从技术领先走向普惠大众，为国内胃癌早筛普及提供更坚实的支撑。","listText":"<a href=\"https://laohu8.com/S/02629\">$MIRXES-B(02629)$</a> 近期举办的西郊会议，再次将消化道肿瘤早筛的规范化、规模化建设推向行业焦点。觅瑞在会上同步发布两项重磅研究计划，背后离不开其成熟的早筛技术与产品支撑。觅小卫作为核心落地产品，凭借稳定的检测性能与无创筛查优势，已在临床与市场端得到广泛应用。此次启动的百万人群队列研究，也将进一步验证卫小觅在真实世界中的应用价值，推动产品从技术领先走向普惠大众，为国内胃癌早筛普及提供更坚实的支撑。","text":"$MIRXES-B(02629)$ 近期举办的西郊会议，再次将消化道肿瘤早筛的规范化、规模化建设推向行业焦点。觅瑞在会上同步发布两项重磅研究计划，背后离不开其成熟的早筛技术与产品支撑。觅小卫作为核心落地产品，凭借稳定的检测性能与无创筛查优势，已在临床与市场端得到广泛应用。此次启动的百万人群队列研究，也将进一步验证卫小觅在真实世界中的应用价值，推动产品从技术领先走向普惠大众，为国内胃癌早筛普及提供更坚实的支撑。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/554166655817760","isVote":1,"tweetType":1,"viewCount":657,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":544231399383944,"gmtCreate":1773894595125,"gmtModify":1773894871235,"author":{"id":"4223082579780710","authorId":"4223082579780710","name":"财经观象台","avatar":"https://static.tigerbbs.com/379ecbe3a955be0e4ded631cc9a6779e","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4223082579780710","authorIdStr":"4223082579780710"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02629\">$MIRXES-B(02629)$</a> 2026年两会卫健委明确划定肺癌、结直肠癌、胃癌等重点癌症高危人群与规范筛查标准，代表委员纷纷建言扩大筛查覆盖面、推进医保支付，叠加《健康中国行动》等政策落地，层层加码筑牢行业根基。觅瑞的核心产品觅小卫®精准契合政策导向，手握国内胃癌早筛三类医疗器械注册证，完美匹配胃癌高危人群的筛查需求，踩准了行业发展的核心节奏。这份顶层设计不仅为早筛普及指明方向，更让合规深耕的企业迎来前所未有的发展窗口期，紧跟政策步伐，才能抢占先机、拉开与同行的差距。","listText":"<a href=\"https://laohu8.com/S/02629\">$MIRXES-B(02629)$</a> 2026年两会卫健委明确划定肺癌、结直肠癌、胃癌等重点癌症高危人群与规范筛查标准，代表委员纷纷建言扩大筛查覆盖面、推进医保支付，叠加《健康中国行动》等政策落地，层层加码筑牢行业根基。觅瑞的核心产品觅小卫®精准契合政策导向，手握国内胃癌早筛三类医疗器械注册证，完美匹配胃癌高危人群的筛查需求，踩准了行业发展的核心节奏。这份顶层设计不仅为早筛普及指明方向，更让合规深耕的企业迎来前所未有的发展窗口期，紧跟政策步伐，才能抢占先机、拉开与同行的差距。","text":"$MIRXES-B(02629)$ 2026年两会卫健委明确划定肺癌、结直肠癌、胃癌等重点癌症高危人群与规范筛查标准，代表委员纷纷建言扩大筛查覆盖面、推进医保支付，叠加《健康中国行动》等政策落地，层层加码筑牢行业根基。觅瑞的核心产品觅小卫®精准契合政策导向，手握国内胃癌早筛三类医疗器械注册证，完美匹配胃癌高危人群的筛查需求，踩准了行业发展的核心节奏。这份顶层设计不仅为早筛普及指明方向，更让合规深耕的企业迎来前所未有的发展窗口期，紧跟政策步伐，才能抢占先机、拉开与同行的差距。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/544231399383944","isVote":1,"tweetType":1,"viewCount":995,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":521851669018056,"gmtCreate":1768441228664,"gmtModify":1768444288582,"author":{"id":"4223082579780710","authorId":"4223082579780710","name":"财经观象台","avatar":"https://static.tigerbbs.com/379ecbe3a955be0e4ded631cc9a6779e","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4223082579780710","authorIdStr":"4223082579780710"},"themes":[],"title":"","htmlText":"<a href=\"https://laohu8.com/S/02629\">$MIRXES-B(02629)$</a> 觅瑞拥有自主研发的miRNA检测专利，其基于miRNA技术研发推出的胃癌早筛产品觅小卫®已经获得第三类医疗器械注册证了，这也是国内首批合规上市的癌症早筛试剂盒，填补了我国无创胃癌早筛领域的空白，有重要的行业意义。","listText":"<a href=\"https://laohu8.com/S/02629\">$MIRXES-B(02629)$</a> 觅瑞拥有自主研发的miRNA检测专利，其基于miRNA技术研发推出的胃癌早筛产品觅小卫®已经获得第三类医疗器械注册证了，这也是国内首批合规上市的癌症早筛试剂盒，填补了我国无创胃癌早筛领域的空白，有重要的行业意义。","text":"$MIRXES-B(02629)$ 觅瑞拥有自主研发的miRNA检测专利，其基于miRNA技术研发推出的胃癌早筛产品觅小卫®已经获得第三类医疗器械注册证了，这也是国内首批合规上市的癌症早筛试剂盒，填补了我国无创胃癌早筛领域的空白，有重要的行业意义。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/521851669018056","isVote":1,"tweetType":1,"viewCount":779,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":487222894326144,"gmtCreate":1759979681406,"gmtModify":1759979773867,"author":{"id":"4223082579780710","authorId":"4223082579780710","name":"财经观象台","avatar":"https://static.tigerbbs.com/379ecbe3a955be0e4ded631cc9a6779e","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4223082579780710","authorIdStr":"4223082579780710"},"themes":[],"title":"","htmlText":"今年在港股上市的生物科技企业Mirxes觅瑞，他们的核心产品是通过检测血液miRNA标志物来完成胃癌筛查，用到的是液体活检技术。作为胃癌高危人群较多的亚洲，这款产品前途不可限量！所以最近也是被建银国际行研报告给出跑赢大盘的评级，而且目标价格是100港元，股价还有潜力的！资本市场也会非常看好，据了解继被纳入港股通后，南向资金流动也很活跃。","listText":"今年在港股上市的生物科技企业Mirxes觅瑞，他们的核心产品是通过检测血液miRNA标志物来完成胃癌筛查，用到的是液体活检技术。作为胃癌高危人群较多的亚洲，这款产品前途不可限量！所以最近也是被建银国际行研报告给出跑赢大盘的评级，而且目标价格是100港元，股价还有潜力的！资本市场也会非常看好，据了解继被纳入港股通后，南向资金流动也很活跃。","text":"今年在港股上市的生物科技企业Mirxes觅瑞，他们的核心产品是通过检测血液miRNA标志物来完成胃癌筛查，用到的是液体活检技术。作为胃癌高危人群较多的亚洲，这款产品前途不可限量！所以最近也是被建银国际行研报告给出跑赢大盘的评级，而且目标价格是100港元，股价还有潜力的！资本市场也会非常看好，据了解继被纳入港股通后，南向资金流动也很活跃。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/487222894326144","isVote":1,"tweetType":1,"viewCount":1065,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"defaultTab":"posts","isTTM":false}